Assertio Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapeutics to address unmet medical needs in various therapeutic areas
With a commitment to improving patient outcomes, the company specializes in delivering treatments for diseases such as pain and other central nervous system disorders. Assertio employs a range of scientific approaches, including the advancement of specialized drug formulations and targeted delivery systems, in order to enhance efficacy and patient adherence to treatment. Through its innovative product offerings and robust pipeline, Assertio aims to provide effective solutions that empower patients to lead healthier lives.
Companies Reporting Before The Bell • Ballard Power Systems (NASDAQBLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million.
Assertio Holdings Inc (NASDAQASRT) shares are trading higher by 12.48% to $3.27 Monday morning, rebounding following Friday's weakness, after the company reported second-quarter financial results and
